Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors

Cancer is one of the major causes of death worldwide. Its treatments usually fail when the tumor has become malignant and metastasized. Metastasis is a key source of cancer recurrence, which often leads to resistance towards chemotherapeutic agents. Hence, most cancer-related deaths are linked to th...

Full description

Bibliographic Details
Published in:Journal of Oncology
Main Author: Tune B.X.J.; Sim M.S.; Poh C.L.; Guad R.M.; Woon C.K.; Hazarika I.; Das A.; Gopinath S.C.B.; Rajan M.; Sekar M.; Subramaniyan V.; Fuloria N.K.; Fuloria S.; Batumalaie K.; Wu Y.S.
Format: Review
Language:English
Published: Hindawi Limited 2022
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85130745213&doi=10.1155%2f2022%2f3249766&partnerID=40&md5=442409d52a50085f42c7b2e1d3ef5e3f
id 2-s2.0-85130745213
spelling 2-s2.0-85130745213
Tune B.X.J.; Sim M.S.; Poh C.L.; Guad R.M.; Woon C.K.; Hazarika I.; Das A.; Gopinath S.C.B.; Rajan M.; Sekar M.; Subramaniyan V.; Fuloria N.K.; Fuloria S.; Batumalaie K.; Wu Y.S.
Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors
2022
Journal of Oncology
2022

10.1155/2022/3249766
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85130745213&doi=10.1155%2f2022%2f3249766&partnerID=40&md5=442409d52a50085f42c7b2e1d3ef5e3f
Cancer is one of the major causes of death worldwide. Its treatments usually fail when the tumor has become malignant and metastasized. Metastasis is a key source of cancer recurrence, which often leads to resistance towards chemotherapeutic agents. Hence, most cancer-related deaths are linked to the occurrence of chemoresistance. Although chemoresistance can emerge through a multitude of mechanisms, chemoresistance and metastasis share a similar pathway, which is an epithelial-to-mesenchymal transition (EMT). Matrix metalloproteinases (MMPs), a class of zinc and calcium-chelated enzymes, are found to be key players in driving cancer migration and metastasis through EMT induction. The aim of this review is to discuss the regulatory roles and associated molecular mechanisms of specific MMPs in regulating chemoresistance, particularly EMT initiation and resistance to apoptosis. A brief presentation on their potential diagnostic and prognostic values was also deciphered. It also aimed to describe existing MMP inhibitors and the potential of utilizing other strategies to inhibit MMPs to reduce chemoresistance, such as upstream inhibition of MMP expressions and MMP-responsive nanomaterials to deliver drugs as well as epigenetic regulations. Hence, manipulation of MMP expression can be a powerful tool to aid in treating patients with chemo-resistant cancers. However, much still needs to be done to bring the solution from bench to bedside. © 2022 Bernadette Xin Jie Tune et al.
Hindawi Limited
16878450
English
Review
All Open Access; Gold Open Access
author Tune B.X.J.; Sim M.S.; Poh C.L.; Guad R.M.; Woon C.K.; Hazarika I.; Das A.; Gopinath S.C.B.; Rajan M.; Sekar M.; Subramaniyan V.; Fuloria N.K.; Fuloria S.; Batumalaie K.; Wu Y.S.
spellingShingle Tune B.X.J.; Sim M.S.; Poh C.L.; Guad R.M.; Woon C.K.; Hazarika I.; Das A.; Gopinath S.C.B.; Rajan M.; Sekar M.; Subramaniyan V.; Fuloria N.K.; Fuloria S.; Batumalaie K.; Wu Y.S.
Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors
author_facet Tune B.X.J.; Sim M.S.; Poh C.L.; Guad R.M.; Woon C.K.; Hazarika I.; Das A.; Gopinath S.C.B.; Rajan M.; Sekar M.; Subramaniyan V.; Fuloria N.K.; Fuloria S.; Batumalaie K.; Wu Y.S.
author_sort Tune B.X.J.; Sim M.S.; Poh C.L.; Guad R.M.; Woon C.K.; Hazarika I.; Das A.; Gopinath S.C.B.; Rajan M.; Sekar M.; Subramaniyan V.; Fuloria N.K.; Fuloria S.; Batumalaie K.; Wu Y.S.
title Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors
title_short Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors
title_full Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors
title_fullStr Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors
title_full_unstemmed Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors
title_sort Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors
publishDate 2022
container_title Journal of Oncology
container_volume 2022
container_issue
doi_str_mv 10.1155/2022/3249766
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85130745213&doi=10.1155%2f2022%2f3249766&partnerID=40&md5=442409d52a50085f42c7b2e1d3ef5e3f
description Cancer is one of the major causes of death worldwide. Its treatments usually fail when the tumor has become malignant and metastasized. Metastasis is a key source of cancer recurrence, which often leads to resistance towards chemotherapeutic agents. Hence, most cancer-related deaths are linked to the occurrence of chemoresistance. Although chemoresistance can emerge through a multitude of mechanisms, chemoresistance and metastasis share a similar pathway, which is an epithelial-to-mesenchymal transition (EMT). Matrix metalloproteinases (MMPs), a class of zinc and calcium-chelated enzymes, are found to be key players in driving cancer migration and metastasis through EMT induction. The aim of this review is to discuss the regulatory roles and associated molecular mechanisms of specific MMPs in regulating chemoresistance, particularly EMT initiation and resistance to apoptosis. A brief presentation on their potential diagnostic and prognostic values was also deciphered. It also aimed to describe existing MMP inhibitors and the potential of utilizing other strategies to inhibit MMPs to reduce chemoresistance, such as upstream inhibition of MMP expressions and MMP-responsive nanomaterials to deliver drugs as well as epigenetic regulations. Hence, manipulation of MMP expression can be a powerful tool to aid in treating patients with chemo-resistant cancers. However, much still needs to be done to bring the solution from bench to bedside. © 2022 Bernadette Xin Jie Tune et al.
publisher Hindawi Limited
issn 16878450
language English
format Review
accesstype All Open Access; Gold Open Access
record_format scopus
collection Scopus
_version_ 1809678158506491904